Succulentoside A
- Family: Plantae - Caryophyllaceae
- Kingdom: Plantae
-
Class: Saponin
- Subclass: Hopane-Type Saponin
Canonical Smiles | O[C@H]1CO[C@H]([C@@H]([C@H]1O[C@@H]1OC[C@@H]([C@@H]([C@H]1O)O)O)O)O[C@H]1C[C@]2(C)[C@@H]([C@@]3([C@@H]1C(C)(C)[C@H](CC3)O[C@@H]1OC[C@H]([C@@H]([C@H]1O)O)O)C)CC[C@H]1[C@@]2(C)C[C@H](O[C@@H]2OC[C@H]([C@@H]([C@H]2O)O)O)[C@@H]2[C@]1(C)CC[C@@H]2C(O)(C)C |
---|---|
InChI | InChI=1S/C50H84O20/c1-45(2)30(69-42-36(59)33(56)23(52)18-64-42)12-14-48(6)29-10-9-28-47(5)13-11-21(46(3,4)62)31(47)26(67-41-35(58)32(55)22(51)17-63-41)15-49(28,7)50(29,8)16-27(40(45)48)68-44-38(61)39(25(54)20-66-44)70-43-37(60)34(57)24(53)19-65-43/h21-44,51-62H,9-20H2,1-8H3/t21-,22+,23+,24-,25-,26-,27-,28+,29+,30-,31+,32-,33-,34-,35+,36+,37+,38+,39-,40-,41-,42-,43-,44-,47+,48+,49+,50+/m0/s1 |
InChIKey | LRYNBNQDQFLUMM-SZHGMKNFSA-N |
Formula | C50H84O20 |
HBA | 20 |
HBD | 12 |
MW | 1005.2 |
Rotatable Bonds | 9 |
TPSA | 316.6 |
LogP | -0.99 |
Number Rings | 9 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 70 |
Formal Charge | 0 |
Fraction CSP3 | 1.0 |
Exact Mass | 1004.56 |
Number of Lipinski Rule Violations | 3 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Polycarpon succulentum | Caryophyllaceae | Plantae | 449198 |
2 | Spergula fallax | Caryophyllaceae | Plantae | 1423401 |
Showing of synonyms
- Meselhy MR, Aboutabl ESA (1997). Hopane-type saponins from Polycarpon succulentum growing in Egypt. Phytochemistry,1997,44(5),925-929. [View]
- Hamed AI, Masullo M, et al. (2014). Unusual fernane and gammacerane glycosides from the aerial parts of Spergula fallax. Journal of Natural Products,2014,77(3),657-662. [View] [PubMed]
No compound-protein relationship available.
SMILES: O1CCCCC1OC(C(C23)CCC2)CC4C3CCC5C4CC(OC(OCC6)CC6OC7CCCCO7)C8C5CCC(C8)OC9CCCCO9
Level: 4
Mol. Weight: 1005.2 g/mol
SMILES: O1CCCCC1OC(C(C23)CCC2)CC4C3CCC5C4CC(OC6CCCCO6)C7C5CCC(C7)OC8CCCCO8
Level: 3
Mol. Weight: 1005.2 g/mol
SMILES: O1CCCCC1OC(C(C23)CCC2)CC4C3CCC5C4CC(C6C5CCCC6)OC(OCC7)CC7OC8CCCCO8
Level: 3
Mol. Weight: 1005.2 g/mol
SMILES: C1CCC(C12)CCC3C2CCC4C3CC(OC(OCC5)CC5OC6CCCCO6)C7C4CCC(C7)OC8CCCCO8
Level: 3
Mol. Weight: 1005.2 g/mol
SMILES: O1CCCCC1OC(C(C23)CCC2)CC4C3CCC5C4CCC6C5CCC(C6)OC7CCCCO7
Level: 2
Mol. Weight: 1005.2 g/mol
SMILES: O1CCCCC1OC(C(C23)CCC2)CC4C3CCC5C4CC(C6C5CCCC6)OC7CCCCO7
Level: 2
Mol. Weight: 1005.2 g/mol
SMILES: C1CCC(C12)CCC3C2CCC4C3CC(OC5CCCCO5)C6C4CCC(C6)OC7CCCCO7
Level: 2
Mol. Weight: 1005.2 g/mol
SMILES: C1CCC(C12)CCC3C2CCC4C3CC(C5C4CCCC5)OC(OCC6)CC6OC7CCCCO7
Level: 2
Mol. Weight: 1005.2 g/mol
SMILES: O1CCCCC1OC(C(C23)CCC2)CC4C3CCC5C4CCC6C5CCCC6
Level: 1
Mol. Weight: 1005.2 g/mol
SMILES: C1CCC(C12)CCC3C2CCC4C3CCC5C4CCC(C5)OC6CCCCO6
Level: 1
Mol. Weight: 1005.2 g/mol
SMILES: C1CCC(C12)CCC3C2CCC4C3CC(C5C4CCCC5)OC6CCCCO6
Level: 1
Mol. Weight: 1005.2 g/mol
SMILES: C1COCCC1OC2CCCCO2
Level: 1
Mol. Weight: 1005.2 g/mol
SMILES: C1CCC(C12)CCC3C2CCC4C3CCC5C4CCCC5
Level: 0
Mol. Weight: 1005.2 g/mol
SMILES: C1CCOCC1
Level: 0
Mol. Weight: 1005.2 g/mol
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -6.4
- Human Oral Bioavailability 20%
- Non-Bioavailable
- Human Intestinal Absorption
- Non-Absorbed
- Madin-Darby Canine Kidney
- 22592.48
- Human Oral Bioavailability 50%
- Non-Bioavailable
- P-Glycoprotein Inhibitor
- Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- 2953390.05
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Non-Penetrable
- Fraction Unbound (Human)
- 0.67
- Plasma Protein Binding
- 87.54
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Inhibitor
Excretion
- Clearance
- 1.03
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Toxic
- Bee
- Safe
- Bioconcentration Factor
- -68684.34
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Toxic
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- -1.35
- Liver Injury II
- Safe
- hERG Blockers
- Toxic
- Daphnia Maga
- 4.05
- Micronucleos
- Toxic
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -5360261047.29
- Rat (Acute)
- 4.31
- Rat (Chronic Oral)
- 12.42
- Fathead Minnow
- 6766192.54
- Respiratory Disease
- Safe
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Toxic
- SR-p53
- Safe
General Properties
- Boiling Point
- 602876875.0
- Hydration Free Energy
- -2.92
- Log(D) at pH=7.4
- -317.12
- Log(P)
- 0.08
- Log S
- -3.04
- Log(Vapor Pressure)
- -19852245.68
- Melting Point
- 322.99
- pKa Acid
- -144556.94
- pKa Basic
- -1144.56
Protein Name | UniProt ID | Entry Name | Species | #Pharmacophore Points | Probability (0.7 ≤ Tversky Score ≤ 1.0) |
---|---|---|---|---|---|
Prolyl tripeptidyl peptidase | Q7MUW6 | PTP_PORGI | Porphyromonas gingivalis | 3 | 0.8572 |
Prolyl tripeptidyl peptidase | Q7MUW6 | PTP_PORGI | Porphyromonas gingivalis | 3 | 0.8572 |
CmeR | Q7B8P6 | Q7B8P6_CAMJU | Campylobacter jejuni | 2 | 0.7862 |
CmeR | Q7B8P6 | Q7B8P6_CAMJU | Campylobacter jejuni | 2 | 0.7862 |